IRD - Bathi sadurunge bunga, pajak, lan amortisasi opusgtx.com

Logo grafis Opus Genetics, Inc. (IRD)

Opus Genetics Inc (IRD) is developing advanced gene therapy methods to combat rare retinal pathologies. Partnerships with scientific foundations are helping to accelerate the release of innovative ophthalmological drops. However, the lack of profitable products leaves the company dependent on external financing, and the absolute EBITDA trend confirms this status, where the value 0.00 captures the current operating profit figure.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: Opus Genetics (IRD) kanggo 23.11.2025 - 10.11.2026

Opus Genetics - rincian analitis lan metrik utama (IRD)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:IRD Opus Genetics Inc
Produk dadi Opus Genetics

Absolute operating profit before interest and taxes measures a business's actual ability to generate cash flow from core operations, excluding the impact of debt load and fiscal policy. By analyzing the EBITDA trend, an investor assesses the commercialization efficiency of Opus Genetics Inc. (IRD), where financial results depend on clinical successes and patents rather than macroeconomic cycles.

Analisis pesaing Opus Genetics Inc

Alcon Corp (ALC) - Bathi sadurunge bunga, pajak, lan amortisasi|Bausch + Lomb Corporation - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi glaukos.com|Apellis (APLS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|BLTE - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ocular Therapeutix Corp|Bathi sadurunge bunga, pajak, lan amortisasi Harrow Corp HROW|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Viridian Therapeutics (VRDN)|LENZ: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Oculis Holding - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA EyePoint Pharmaceuticals Inc EYPT|KOD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Aldeyra Therapeutics ALDX|KALA (kalarx.com) - Bathi operasional sadurunge ngurangi amortisasi|OKYO Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|ADVM (Adverum Biotechnologies Inc.) - Bathi operasional EBITDA|OTLK - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA CLSD|NBY - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Kiora Pharmaceuticals, Inc. KPRX|ALIM: Bathi operasional sadurunge amortisasi|Eyenovia Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Guardion Health Sciences, Inc.|OCUP (Ocuphire) - Bathi operasional sadurunge ngurangi amortisasi|OPT: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi